<DOC>
	<DOC>NCT03088137</DOC>
	<brief_summary>The purpose of this study is to show equivalence with regard to the number of oocytes retrieved between follitropin alfa (pen-injectors) Primapur® and Gonal-f® in woman undergoing IVF/ICSI</brief_summary>
	<brief_title>Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility, Female</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Infertility due to tubal factor and/or male factor Age between 20 and 35 years with regular menstrual cycles of 2135 days First or second cycle in the present series of ART BMI ≥ 18 ≤ 30 kg/m2 Basal FSH &lt; 10 IU/L (cycle day 25) E2 levels &lt; 50pg/mL (cycle day 2) AMH ≥ 1.0 ng/ml Antral follicle count (AFC) ≥ 4 to ≤ 15 follicles (both ovaries) Presence of both ovaries and normal uterine cavity Informed consent Presence of pregnancy Hypersensitivity to follitropin alfa Ovarian cysts History of ≥2 succeeding ART cycles (IVF and/or ICSI) before the study cycle Previous history of severe ovarian hyperstimulation syndrome Presence of polycystic ovaries (PCO) Presence of endometriosis and hydrosalpinx Presence of uterine disorders History of poor (&lt; 4 oocytes) or hyper (&gt; 25 oocytes) responses to FSH treatment at dose 150 IU and GnRHantagonist protocol Premature ovarian failure Ectopic pregnancy (3 month before the study cycle) Presence of clinically significant systemic disease Presence of chronic cardiovascular, hepatic, renal or pulmonary disease Presence of endocrine disorder Neoplasia Male infertility without mobile spermatozoa in the ejaculate, that need MESA/TESE/TESA Smoking &gt; 10 cigarettes/day Narcomania, alcoholism Planned PGS/PGD</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>in vitro fertilization</keyword>
</DOC>